Zobrazeno 1 - 10
of 313
pro vyhledávání: '"Reggiardo P"'
Autor:
FEDERICO PIÑERO, Margarita Anders, Carla Bermúdez, Diego Arufe, Adriana Varón, Ana Palazzo, Jorge Rodriguez, Oscar Beltrán, Daniela Simian, Leonardo Gomes da Fonseca, Ezequiel Ridruejo, Norberto Tamagnone, Hugo Cheinquer, Diana Bejarano, Juan Ignacio Marín, Federico Orozco Ganem, Josefina Pagés, Jaime Poniachik, Sebastián Marciano, Virginia Reggiardo, Manuel Mendizabal
Publikováno v:
Annals of Hepatology, Vol 29, Iss , Pp 101598- (2024)
Conflict of interest: No Introduction and Objectives: The term “recompensation” of cirrhosis was proposed in the latest BAVENO VII, underlying dynamic events and prognosis in cirrhosis. However, there is uncertainty regarding its prognosis in pat
Externí odkaz:
https://doaj.org/article/47ffc5b43a5c48619b067fce6d8e0f8b
Autor:
FERNANDO BESSONE, Ismael Alvarez Alvarez, Nelia Hernandez, Maria Isabel Schinoni, Inmaculada Medina Caliz, Hugo Tanno, Hao Niu, Maria Virginia Reggiardo, Federico Tanno, Gabriel Rifrani, Ezequiel Ridruejo, Manuel Mendizabal, Raymundo Paraná, Eduardo Luis Fassio, Daiana Arnedillo, Antonella Cordone, Daniela Chiodi, Gisela Gualano, Javier Brahm, Maria Isabel Lucena Gonzalez, Raúl Jesus Andrade
Publikováno v:
Annals of Hepatology, Vol 29, Iss , Pp 101608- (2024)
Conflict of interest: No Introduction and Objectives: Background: Non-steroidal anti-inflammatory drugs (NSAIDs) represent a frequent cause of drug-induced liver injury (DILI). Aim: To compare demographics, clinical characteristics and outcomes of NS
Externí odkaz:
https://doaj.org/article/4d2ad7fdbde0494487daff066c2a553b
Autor:
FEDERICO PIÑERO, Margarita Anders, Carla Bermúdez, Diego Arufe, Adriana Varón, Ana Palazzo, Jorge Rodríguez, Oscar Beltrán, Patricio Palavecino Rubilar, Leonardo Gomes da Fonseca, Ezequiel Ridruejo, Norberto Tamagnone, Hugo Cheinquer, Nicolás Cortés Medina, Juan Ignacio Marín, Estela Manero, Federico Orozco Ganem, Jaime Poniachik, Sebastián Marciano, Virginia Reggiardo, Manuel Mendizabal
Publikováno v:
Annals of Hepatology, Vol 29, Iss , Pp 101646- (2024)
Conflict of interest: No Introduction and Objectives: Stopping rules following transarterial chemoembolization (TACE), either tumor progression or “unTACEable” progression are needed. Avoiding liver decompensation after TACE may lead better acces
Externí odkaz:
https://doaj.org/article/834807ca9d51493ba91791ccf7efa94c
Autor:
Maria Mercedes Cortese, Lucas Muñoz, Gabriel Rifrani, Natalia Ahumada, Daiana Arnedillo, Antonella Cordone, Morena Carvalho, Martina Rigoni, Alceo Galimberti, Norberto Tamagnone, Federico Tanno, Hugo Tanno, Lucia Hernandez, Maria Virginia Reggiardo, Fernando Bessone
Publikováno v:
Annals of Hepatology, Vol 29, Iss , Pp 101685- (2024)
Conflict of interest: No Introduction and Objectives: Losing weight and lifestyle modifications are still pillars of treatment for metabolic associated steatotic liver disease (MASLD) and steatohepatitis (MASH), despite the emerging therapies. Bariat
Externí odkaz:
https://doaj.org/article/ba7ac2664e7641f0aeda0b149ce8557a
Autor:
Viviana Giannuzzi, Arianna Bertolani, Silvia Torretta, Giorgio Reggiardo, Eleonora Toich, Donato Bonifazi, Adriana Ceci
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionThe European Medicines Agency (EMA) offers scientific advice to support the qualification procedure of novel methodologies, such as preclinical and in vitro models, biomarkers, and pharmacometric methods, thereby endorsing their acceptabi
Externí odkaz:
https://doaj.org/article/8a34c496f14547ed9df7bdb0329ccc41
Autor:
Anando Sen, Victoria Hedley, Eva Degraeuwe, Steven Hirschfeld, Ronald Cornet, Ramona Walls, John Owen, Peter N. Robinson, Edward G. Neilan, Thomas Liener, Giovanni Nisato, Neena Modi, Simon Woodworth, Avril Palmeri, Ricarda Gaentzsch, Melissa Walsh, Teresa Berkery, Joanne Lee, Laura Persijn, Kasey Baker, Kristina An Haack, Sonia Segovia Simon, Julius O. B. Jacobsen, Giorgio Reggiardo, Melissa A. Kirwin, Jessie Trueman, Claudia Pansieri, Donato Bonifazi, Sinéad Nally, Fedele Bonifazi, Rebecca Leary, Volker Straub
Publikováno v:
Data, Vol 9, Iss 4, p 55 (2024)
The conect4children (c4c) initiative was established to facilitate the development of new drugs and other therapies for paediatric patients. It is widely recognised that there are not enough medicines tested for all relevant ages of the paediatric po
Externí odkaz:
https://doaj.org/article/e7a77672ae75448a8d6368c5e0e60542
Autor:
Mariagrazia Felisi, Fedele Bonifazi, Maddalena Toma, Claudia Pansieri, Rebecca Leary, Victoria Hedley, Ronald Cornet, Giorgio Reggiardo, Annalisa Landi, Annunziata D’Ercole, Salma Malik, Sinéad Nally, Anando Sen, Avril Palmeri, Donato Bonifazi, Adriana Ceci
Publikováno v:
Data, Vol 9, Iss 4, p 59 (2024)
The reuse of paediatric individual patient data (IPD) from clinical trials (CTs) is essential to overcome specific ethical, regulatory, methodological, and economic issues that hinder the progress of paediatric research. Sharing data through reposito
Externí odkaz:
https://doaj.org/article/9158e49a93a246568a90d8f1c50b1cc2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Federico Piñero, Margarita Anders, Carla Bermudez, Ezequiel Demirdjian, Adriana Varón, Ana Palazzo, Jorge Rodriguez, Oscar Beltrán, Leonardo Gomes da Fonseca, Ezequiel Ridruejo, Pablo Caballini, Norberto Tamagnone, Virginia Reggiardo, Hugo Cheinquer, Alexandre Araujo, Diego Arufe, Juan Ignacio Marín, Natalia Ratusnu, Estela Manero, Daniela Perez, Marina Villa, Federico Orozco, Dolores Murga, Sebastián Marciano, Fernando Bessone, Marcelo Silva, Manuel Mendizabal
Publikováno v:
Annals of Hepatology, Vol 28, Iss 4, Pp 101110- (2023)
Introduction and Objectives: With the advent of new therapeutic options for patients with hepatocellular carcinoma (HCC) for intermediate or advanced stages of the Barcelona Clinic Liver Cancer (BCLC), regional real-world data regarding prognostic su
Externí odkaz:
https://doaj.org/article/e6700345279449dea0ac19f417f34afe
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Recent phase II pilot clinical trials suggested that tauro-urso-deoxycholic acid (TUDCA) might slow functional decline and increase survival in patients with amyotrophic lateral sclerosis (ALS). We performed a multivariate analysis of the original TU
Externí odkaz:
https://doaj.org/article/79e709b9ddb64182a5671278fd4e8a29